The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,096.00
Ask: 12,098.00
Change: 46.00 (0.38%)
Spread: 2.00 (0.017%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London Schools To Remain Closed As Covid Vaccination Programme Expands

Sat, 02nd Jan 2021 11:48

(Alliance News) - London schools will remain closed next week as the UK prepares to ramp up its coronavirus vaccination programme.

Education Secretary Gavin Williamson on Friday confirmed that all London primary schools will remain shut next week as the capital battles with high levels of coronavirus infections.

But while the move was welcomed as the "right decision", the government was also accused of making another U-turn just days after it told some schools to reopen for the new term.

Labour shadow education secretary Kate Green said the last-minute nature of the government's decision had caused "huge stress" for pupils, families and staff.

She said: "This is yet another government U-turn creating chaos for parents just two days before the start of term."

The row comes as new figures showed a further 53,285 lab-confirmed cases of coronavirus in the UK as of 9am on Friday, with another 613 deaths within 28 days of a positive test.

This is the fourth day in a row daily cases have been above 50,000, with a new record high of 55,892 cases reported on New Year's Eve – the highest since mass testing began in late May.

NHS England also said that a further 420 people who tested positive for coronavirus had died in hospital in England, including an eight-year-old child with an underlying health condition.

Separate figures published by the UK's statistics agencies for deaths where Covid-19 has been mentioned on the death certificate, together with additional data on fatalities that have occurred in recent days, show there have now been 90,000 deaths involving Covid-19 in the UK.

The UK is also preparing to send out the new Oxford University and AstraZeneca PLC vaccine with 530,000 doses available for rollout from Monday.

The Times reported that a member of the Oxford/AstraZeneca team had said two million doses of the Oxford vaccine are due to be supplied each week by the middle of January.

It comes after the UK's chief medical officers warned on Thursday that vaccine shortage was a "reality that cannot be wished away".

Rollout of the Pfizer Inc and BioNTech SE jab began almost a month ago but second doses of either vaccine will now take place within 12 weeks rather than 21 days as initially planned.

More than a million people have received their first coronavirus vaccination but in a joint statement England's chief medical officer, Chris Whitty, and his counterparts in Scotland, Wales and Northern Ireland said the public will "understand" and "thank" them for the plan to give first jabs as a priority, delaying the follow-up vaccination for others.

David Salisbury, a former director of immunisation at the Department of Health, said he backs the revised Covid-19 vaccine strategy.

The associate fellow at the Chatham House think tank told BBC Radio 4's Today programme: "Of course I accept it is inconvenient and isn't helpful to have to change appointments and explain to people [about the delay in receiving a second jab], but the reason for doing this is to save lives.

"We know how many have been vaccinated, and across the whole country it isn't all that many, but every time we give a second dose right now, we are holding that back from someone who is likely, if they get coronavirus, to die, and much more likely to die than somebody who has already had a single dose."

Williamson said the decision to close all London primary schools had been a "last resort".

Under the government's initial plan, secondary schools and colleges were set to be closed to most pupils for the first two weeks of January, while primary schools within 50 local authorities in London and the south of England were also told to keep their doors shut.

But in a change to those primary school proposals, Williamson said: "As infection rates rise across the country, and particularly in London, we must make this move to protect our country and the NHS.

"We will continue to keep the list of local authorities under review, and reopen classrooms as soon as we possibly can."

The decision comes after leaders of eight London boroughs asked Williamson to reverse the decision, pointing out that some areas on the closure list had lower infection rates than those where schools had been told to reopen.

London Mayor Sadiq Khan welcomed the U-turn and said: "This is the right decision."

Meanwhile a senior medic told the PA news agency that people needed to follow guidance on handwashing, social distancing and face coverings to stop the "entirely preventable" spread of coronavirus

Adrian Boyle, vice-president of the Royal College of Emergency Medicine, said staff are tired, feel helpless and at risk of burnout.

He told the PA the idea that coronavirus cannot be controlled just "doesn't wash".

Dr Boyle added: "We are worried about staff burnout, staff are tired, they have worked really hard over the summer, they have put up with a lot of disruption.

"This time people are frustrated, this is now an entirely preventable disease, we know what we did in spring made a lot of this go away. There's also now a vaccine.

"The idea that we are dealing with something that can't be controlled doesn't wash, this is a preventable disease and we need to be preventing it."

Boyle said washing hands, wearing face coverings and keeping your distance from others stops the spread of the infection, and he also thanked people for not partying on New Year's Eve.

By Joe Gammie, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.